T cell depletion in paediatric stem cell transplantation

Area of Science:

• Pediatric Hematology
• Immunology
• Transplantation Science

Background:

• Hematopoietic stem cell transplantation (HSCT) is a curative option for many pediatric diseases.
• The increasing use of HSCT necessitates identifying suitable stem cell donors beyond matched siblings.
• Alternative donors like unrelated, cord blood, or haploidentical related donors are used, but graft-versus-host disease (GvHD) remains a challenge.

Purpose of the Study:

• To review recent pediatric outcomes for T cell-depleted HSCT.
• To explore the role of serotherapy in conditioning regimens for HSCT.
• To discuss future strategies for improving HSCT outcomes in children.

Main Methods:

• Review of recent pediatric outcome data for T cell-depleted HSCT.
• Exploration of serotherapy's role in conditioning regimens.
• Discussion of novel allodepletion techniques, suicide gene therapy, and immunotherapy.

Main Results:

• T cell depletion (TCD) in HSCT aims to reduce GvHD but can delay immune reconstitution and increase infections and relapse.
• Paediatric data suggest that shifting from positive selection to negative depletion of specific cells in haploidentical HSCT enhances immune reconstitution and disease-free survival.
• Optimizing TCD strategies is crucial for improving HSCT efficacy in children.

Conclusions:

• T cell-depleted HSCT outcomes in children are improving, particularly with refined depletion techniques.
• Future research should focus on novel TCD methods, serotherapy optimization, and advanced immunotherapies to further enhance HSCT success rates in pediatric patients.
• Balancing GvHD reduction with robust immune reconstitution is key to improving survival and reducing relapse in pediatric HSCT.